IN2013CN09358A - - Google Patents

Download PDF

Info

Publication number
IN2013CN09358A
IN2013CN09358A IN9358CHN2013A IN2013CN09358A IN 2013CN09358 A IN2013CN09358 A IN 2013CN09358A IN 9358CHN2013 A IN9358CHN2013 A IN 9358CHN2013A IN 2013CN09358 A IN2013CN09358 A IN 2013CN09358A
Authority
IN
India
Prior art keywords
soyasapogenol
composition
glucuronopyranosyl
soy saponin
weight ratio
Prior art date
Application number
Other languages
English (en)
Inventor
Shuichi Kamo
Toshiro Sato
Shunsuke Suzuki
Original Assignee
J Oil Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Oil Mills Inc filed Critical J Oil Mills Inc
Publication of IN2013CN09358A publication Critical patent/IN2013CN09358A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
IN9358CHN2013 2011-06-28 2012-04-11 IN2013CN09358A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011142434 2011-06-28
PCT/JP2012/059845 WO2013001890A1 (ja) 2011-06-28 2012-04-11 ソーヤサポゲノール組成物

Publications (1)

Publication Number Publication Date
IN2013CN09358A true IN2013CN09358A (ja) 2015-08-14

Family

ID=47423798

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9358CHN2013 IN2013CN09358A (ja) 2011-06-28 2012-04-11

Country Status (9)

Country Link
US (1) US9216187B2 (ja)
EP (1) EP2727586A4 (ja)
JP (2) JP6018571B2 (ja)
KR (1) KR20140037107A (ja)
CN (1) CN103635184B (ja)
BR (1) BR112013032777A2 (ja)
IN (1) IN2013CN09358A (ja)
TW (1) TWI445536B (ja)
WO (1) WO2013001890A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5483786B1 (ja) * 2012-07-24 2014-05-07 株式会社Ｊ−オイルミルズ 組成物
KR101556849B1 (ko) 2014-04-25 2015-10-02 경희대학교 산학협력단 소야사포닌-i을 포함하는 신경줄기세포 또는 신경전구세포의 분화 또는 증식 촉진용 조성물
KR102406000B1 (ko) * 2015-09-30 2022-06-08 (주)아모레퍼시픽 소야사포닌을 함유하는 발모 및/또는 육모 촉진용 조성물
KR102417301B1 (ko) * 2015-10-30 2022-07-06 (주)아모레퍼시픽 소야사포닌을 함유하는 피부 미백용 조성물
US9790007B2 (en) 2015-11-24 2017-10-17 Runway Blue, Llc Lid for a container
WO2019208627A1 (ja) * 2018-04-27 2019-10-31 サントリーホールディングス株式会社 筋肉量減少抑制用、筋力低下抑制用、筋肉量増加用又は筋力増加用の組成物
CN108558985B (zh) * 2018-05-19 2019-06-07 河南省科学院高新技术研究中心 白桦脂酸衍生物及其合成方法和应用
EP4052701A4 (en) * 2019-10-30 2023-11-15 Suntory Holdings Limited COMPOSITION FOR TGR5 ACTIVATION

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822120B2 (ja) * 1978-03-31 1983-05-06 大塚製薬株式会社 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ
JPH10234396A (ja) * 1997-02-25 1998-09-08 Nippon Kayaku Co Ltd 新規抗腫瘍剤およびソヤサポゲノールｂの製造法
FR2779058B1 (fr) 1998-05-29 2003-02-21 Dior Christian Parfums Utilisation d'au moins une saponine ou un sapogenol cosmetiquement acceptable, comme agent cosmetique destine a augmenter la quantite de collagene iv dans la jonction dermo-epidermique
JP2000078955A (ja) * 1998-06-23 2000-03-21 Ezaki Glico Co Ltd 飲食物および薬品
JP2002128663A (ja) * 2000-10-19 2002-05-09 Kikkoman Corp ソヤサポゲノールｂを有効成分とする抗アレルギー剤
JP2005137201A (ja) 2001-04-16 2005-06-02 Meiji Seika Kaisha Ltd ソヤサポゲノールｂの製造法
EP1403373B1 (en) 2001-06-06 2011-09-28 Meiji Seika Pharma Co., Ltd. Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
JP3670609B2 (ja) 2001-12-25 2005-07-13 株式会社大阪薬品研究所 ダイズサポニン類誘導体を含有した抗酸化剤
JP4428054B2 (ja) 2002-03-14 2010-03-10 不二製油株式会社 大豆サポニン含有物及びその製造法
JP2006213649A (ja) 2005-02-03 2006-08-17 Osaka Yakuhin Kenkyusho:Kk 大豆サポニンからなる細胞賦活剤、コラーゲン産生促進剤及び抗酸化剤、並びに該細胞賦活剤、該コラーゲン産生促進剤及び／又は該抗酸化剤を含有する化粧料原料、並びに該化粧料原料を含有する化粧料組成物
EP2157086B1 (en) 2007-06-21 2012-10-10 J-Oil Mills, Inc. Method for producing glycoside aglycone
JP5419366B2 (ja) * 2008-03-03 2014-02-19 東洋精糖株式会社 生体吸収性に優れたヘスペレチン組成物
WO2010150612A1 (ja) 2009-06-22 2010-12-29 株式会社Ｊ－オイルミルズ ヒアルロン酸産生促進剤及びメラニン生成抑制剤
JP5133373B2 (ja) * 2010-07-05 2013-01-30 株式会社ファンケル ベータグルコシダーゼ活性増強剤及び生理活性配糖体の吸収促進剤

Also Published As

Publication number Publication date
WO2013001890A1 (ja) 2013-01-03
KR20140037107A (ko) 2014-03-26
TW201328696A (zh) 2013-07-16
EP2727586A1 (en) 2014-05-07
JP2016193941A (ja) 2016-11-17
JPWO2013001890A1 (ja) 2015-02-23
CN103635184B (zh) 2016-02-10
JP6018571B2 (ja) 2016-11-02
US20140121177A1 (en) 2014-05-01
US9216187B2 (en) 2015-12-22
CN103635184A (zh) 2014-03-12
JP6140347B2 (ja) 2017-05-31
EP2727586A4 (en) 2014-11-26
TWI445536B (zh) 2014-07-21
BR112013032777A2 (pt) 2017-01-24

Similar Documents

Publication Publication Date Title
IN2013CN09358A (ja)
MX342797B (es) Glucósido(s) de terpeno de solubilidad mejorada.
ZA201309667B (en) Milk oligosaccharide-galactooligosaccharide composition for infact formula containing the soluble oligosaccharide fraction present in milk,and having a low level of monosaccharides,and a process to produce the composition
GB2488918A (en) Sugar mixtures and methods for production and use thereof
MX338916B (es) Oxazepinas como moduladores del canal de iones.
GT201200117A (es) Derivados de glicósido y usos de los mismos
MX363512B (es) Proceso de glicoconjugacion.
MY165645A (en) Cleansing composition with decyl and coco glucosides
MX2014004694A (es) Composiciones.
WO2012145346A3 (en) Nutritional compositions for enhancing performance and methods for making and using same
MX2019009100A (es) Nuevos derivados de triazolo[4,5-d]pirimidina.
UA103373C2 (ru) Стабильное соединение феррума олигосахарида
SG10201805198TA (en) 18f - fluciclovine compositions in citrate buffers
HK1141790A1 (ja)
MY171201A (en) New carbamate glycolipid and use thereof
WO2007041564A3 (en) (s)-6-methyloxaalkyl exemestane compounds and related methods of use
IN2014MN01469A (ja)
MY153899A (en) Compositions containing sesamin-class compound(s) and quercetin glycoside(s)
IN2015DN00085A (ja)
GB201309925D0 (en) Preparation method for caspofungin analog
NZ626540A (en) Glutamine enriched nutritional composition for preterm infants
WO2011103586A3 (en) Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
BR112015017583A2 (pt) n-metilserotonina e substâncias relacionadas para utilização em tratamento/diminuição da ocorrência de ondas de calor associadas a menopausa
TW201129357A (en) Novel compound, antitumor agent, and medicines, food or cosmetics with antitumor action
MD3609G2 (ro) Procedeu de cultivare a mărului